Thank you, Chair.
Thank you to the witnesses.
My first question goes to you, Ms. Hanson. London, Ontario, is where I'm from. It's the city I represent in the House of Commons. As you know, Western University is a leading centre in terms of diabetes research as far as universities are concerned, so I'm prompted to ask about diabetes and the connection between individuals suffering diabetes and pharmacare.
Some estimates have put forward the idea that medication and diabetes supplies range between $1,000 and $15,000 per individual on an annual basis. When I think about low-income Canadians, when I think about middle-income Canadians, that's an enormous cost, an enormous burden to bear for individuals and families. I wonder if you could tell us your organization's view on pharmacare, given that context.